Patent in US granted for DNA-FACE™
- BioVentures
- Dec 31, 2020
- 1 min read
Updated: Mar 21, 2021
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes has been granted with United States patent no US 10,874,735 B2.
Comments